Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 048870122 approvals

Synergy Innovation Co., Ltd.

Official website

Synergy Innovation, founded in 1998 and KOSDAQ-listed in 2004, manufactures and sells microbial culture media.

As of 2026-10-10, Synergy Innovation Co., Ltd. has 122 Korean MFDS device approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1998 and listed on KOSDAQ in 2004, Synergy Innovation manufactures and sells microbial culture media. It supplies microbial culture media, used as reagents for in-vitro diagnostic analyzers and for environmental monitoring in pharmaceutical manufacturing, to hospitals, testing centers, and pharmaceutical companies nationwide, and holds ISO13485 and medical device KGMP certifications. It operates through 7 consolidated subsidiaries across biotechnology, medical, and health functional food divisions, and invests in drug development via subsidiary Neurobiogen, recording cumulative 2025 revenue of KRW 113.1 billion.

Regulatory approvals

data.go.kr

122 Korean MFDS device approvals · 2013–2026

  • MFDSIVD reagents and media for antibiotic susceptibility2026-10-01
    Product approval · Class 2체외 제인 26-4897 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2026-09-30
    Product approval · Class 1체외 제신 26-1194 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2026-09-09
    Product approval · Class 1체외 제신 26-1101 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2024-08-20
    Product approval · Class 1체외 제신 24-1057 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2023-06-19
    Product approval · Class 1체외 제신 23-940 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-08-18
    Product approval · Class 1체외 제신 22-1149 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-06-23
    Product approval · Class 1체외 제신 22-852 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-28
    Product approval · Class 1체외 제신 22-137 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-28
    Product approval · Class 1체외 제신 22-136 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-28
    Product approval · Class 1체외 제신 22-135 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2022-01-13
    Product approval · Class 1체외 제신 22-64 호
  • MFDSIVD reagents and media for antibiotic susceptibility2021-12-20
    Product approval · Class 2체외 제인 21-5058 호
Show 68 more
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2021-09-17
    Product approval · Class 2체외 제인 21-4815 호
  • MFDSSpecimen transport mediaRevoked2020-11-18
    Product approval · Class 1체외 제신 20-1670 호
  • MFDSSpecimen transport mediaRevoked2020-11-06
    Product approval · Class 1체외 제신 20-1633 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-09-24
    Product approval · Class 1체외 제신 20-1463 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-08-05
    Product approval · Class 1체외 제신 20-1179 호
  • MFDSSpecimen transport media2020-07-16
    Product approval · Class 1체외 제신 20-1086 호
  • MFDSSpecimen transport media2020-06-24
    Product approval · Class 1체외 제신 20-930 호
  • MFDSSpecimen transport media2020-06-17
    Product approval · Class 1체외 제신 20-887 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-03-27
    Product approval · Class 1체외 제신 20-439 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-02-04
    Product approval · Class 1체외 제신 20-140 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-02-03
    Product approval · Class 1체외 제신 20-135 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2020-02-03
    Product approval · Class 1체외 제신 20-136 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2019-04-19
    Product approval · Class 1체외 제신 19-504 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2019-04-18
    Product approval · Class 1체외 제신 19-498 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2016-07-01
    Product approval · Class 1체외 제신 16-810 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2016-07-01
    Product approval · Class 1체외 제신 16-808 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-10-29
    Product approval · Class 1체외 제신 15-324 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-09-15
    Product approval · Class 1체외 제신 15-141 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-09-15
    Product approval · Class 1체외 제신 15-142 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-06-19
    Product approval · Class 1경인 체외 제신 15-324 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-02-09
    Product approval · Class 1경인 체외 제신 15-66 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2015-02-09
    Product approval · Class 1경인 체외 제신 15-65 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-10-14
    Product approval · Class 1경인 체외 제신 14-580 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-08-01
    Product approval · Class 1경인 체외 제신 14-452 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-08-01
    Product approval · Class 1경인 체외 제신 14-451 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-08-01
    Product approval · Class 1경인 체외 제신 14-450 호
  • MFDSIVD reagents and media for antibiotic susceptibility2014-02-28
    Product approval · Class 2체외 제인 14-511 호
  • MFDSIVD reagents and media for antibiotic susceptibility2014-02-28
    Product approval · Class 2체외 제인 14-512 호
  • MFDSIVD reagents and media for antibiotic susceptibility2014-02-28
    Product approval · Class 2체외 제인 14-513 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-01-08
    Product approval · Class 1경인 체외 제신 14-27 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2014-01-08
    Product approval · Class 1경인 체외 제신 14-20 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-19 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1체외 제신 14-21 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-22 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-23 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-24 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-25 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-26 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-28 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2014-01-08
    Product approval · Class 1경인 체외 제신 14-29 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-677 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-678 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-679 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-680 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-681 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-30
    Product approval · Class 1경인 체외 제신 13-682 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-667 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-665 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-664 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-662 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-657 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-651 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-648 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-647 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-645 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-643 호
  • MFDSIVD reagents for staining or culturing clinical microbiologyRevoked2013-12-24
    Product approval · Class 1경인 체외 제신 13-636 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-627 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-628 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-629 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-630 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-631 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-632 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-633 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-634 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-635 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-637 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2013-12-24
    Product approval · Class 1경인 체외 제신 13-638 호

Showing the 80 most recent of 122 records.

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 203 more patents

AI reads

MAA server logs · IP-verified
45
Times AI engines pulled Synergy Innovation Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

45
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 0
Last 7 days
37
live 0
Last 30 days
45
live 0
All time
  • OpenAIOAI-SearchBot35
  • PerplexityPerplexityBot4
  • GoogleGoogleOther3
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Synergy Innovation Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

QuantaMatrix Incorporated2 shared

Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.

Aimed Bio Inc.1 shared

KOSDAQ-listed ADC oncology biotech that has out-licensed pipeline candidates to Biohaven, SK Plasma, and Boehringer Ingelheim.

Ensol Biosciences Inc.1 shared

Ensol Biosciences is a KONEX-listed biotech developing short peptide therapeutics that modulate protein-protein interactions (PPI).

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

Xcell Therapeutics Inc.1 shared

Xcell Therapeutics develops the domestically produced CellCor™ cell culture media series for cell and gene therapy manufacturing.

PCL. Inc1 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

AIOBIO Co., Ltd.1 shared

Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.

BIONEERCORPORATION1 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

Optipharm.CO.,LTD1 shared

Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.

Genomictree Inc.1 shared

Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.

SD BIOSENSOR INC.1 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition